Ke Yuan

Ke Yuan

Auto-generated profile, based on publicly available information

Ke Yuan

University of Glasgow

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 February 2020 in Nature
Verified
Journal Article
Open access
PDF file
MGMoritz Gerstung
Moritz Gerstung
CJClemency Jolly
Clemency Jolly
ILIgnaty Leshchiner
Ignaty Leshchiner
SDStefan C. Dentro
Stefan C. Dentro
SGSantiago Gonzalez
Santiago Gonzalez
PLPeter Van Loo
Peter Van Loo
Cancer develops through a process of somatic evolution1,2. Sequencing data from a single biopsy represent a snapshot of this process that can reveal the timing of specific genomic aberrations and the changing influence of mutational processes3. Here, by whole-genome sequencing analysis of 2,658 cancers as part of the Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium of the International Cancer Genome Consortium (ICGC) and The Cancer Genome Atlas (TCGA)4, we reconstruct the life history and evolution of mutational processes and driver mutation sequences of 38 types of cancer. Early oncogenesis is characterized by mutations in a constrained set of driver genes, and specific copy number gains, such as trisomy 7 in glioblastoma and isochromosome 17q in medulloblastoma. The mutational spectrum changes significantly throughout tumour evolution in 40% of samples. A nearly fourfold diversification of driver genes and increased genomic instability are features of later stages. Copy number alterations often occur in mitotic crises, and lead to simultaneous gains of chromosomal segments. Timing analyses suggest that driver mutations often precede diagnosis by many years, if not decades. Together, these results determine the evolutionary trajectories of cancer, and highlight opportunities for early cancer detection.

11 June 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
AQAdalberto Claudio Quiros
Adalberto Claudio Quiros
NCNicolas Coudray
Nicolas Coudray
AYAnna Yeaton
Anna Yeaton
XYXinyu Yang
Xinyu Yang
BLBojing Liu
Bojing Liu
KYKe Yuan
Ke Yuan
Cancer diagnosis and management depend upon the extraction of complex information from microscopy images by pathologists, which requires time-consuming expert interpretation prone to human bias. Supervised deep learning approaches have proven powerful, but are inherently limited by the cost and quality of annotations used for training. Therefore, we present Histomorphological Phenotype Learning, a self-supervised methodology requiring no labels and operating via the automatic discovery of discriminatory features in image tiles. Tiles are grouped into morphologically similar clusters which constitute an atlas of histomorphological phenotypes (HP-Atlas), revealing trajectories from benign to malignant tissue via inflammatory and reactive phenotypes. These clusters have distinct features which can be identified using orthogonal methods, linking histologic, molecular and clinical phenotypes. Applied to lung cancer, we show that they align closely with patient survival, with histopathologically recognised tumor types and growth patterns, and with transcriptomic measures of immunophenotype. These properties are maintained in a multi-cancer study.

1 July 2018 in Journal of Hepatology
Verified
Journal Article
Closed access
LDLiang-Qing Dong
Liang-Qing Dong
YSYang Shi
Yang Shi
LMLi-Jie Ma
Li-Jie Ma
LYLiu-Xiao Yang
Liu-Xiao Yang
XWXiao-Ying Wang
Xiao-Ying Wang
QGQiang Gao
Qiang Gao

22 March 2021 in Machine Learning for Biomedical Imaging
Verified
Journal Article
Open access
PDF file
AQAdalberto Claudio Quiros
Adalberto Claudio Quiros
RMRoderick Murray-Smith
Roderick Murray-Smith
KYKe Yuan
Ke Yuan
Histopathological images of tumours contain abundant information about how tumours grow and how they interact with their micro-environment. Better understanding of tissue phenotypes in these images could reveal novel determinants of pathological processes underlying cancer, and in turn improve diagnosis and treatment options. Advances of Deep learning makes it ideal to achieve those goals, however, its application is limited by the cost of high quality labels from patients data. Unsupervised learning, in particular, deep generative models with representation learning properties provides an alternative path to further understand cancer tissue phenotypes, capturing tissue morphologies. In this paper, we develop a framework which allows Generative Adversarial Networks (GANs) to capture key tissue features and uses these characteristics to give structure to its latent space. To this end, we trained our model on two different datasets, an H&E colorectal cancer tissue from the National Center for Tumor diseases (NCT, Germany) and an H&E breast cancer tissue from the Netherlands Cancer Institute (NKI, Netherlands) and Vancouver General Hospital (VGH, Canada). Composed of 86 slide images and 576 tissue micro-arrays (TMAs) respectively. We show that our model generates high quality images, with a Frechet Inception Distance (FID) of 16.65 (breast cancer) and 32.05 (colorectal cancer). We further assess the quality of the images with cancer tissue characteristics (e.g. count of cancer, lymphocytes, or stromal cells), using quantitative information to calculate the FID and showing consistent performance of 9.86. Additionally, the latent space of our model shows an interpretable structure and allows semantic vector operations that translate into tissue feature transformations. Furthermore, ratings from two expert pathologists found no significant difference between our generated tissue images from real ones. The code, generated images, and pretrained model are available at https://github.com/AdalbertoCq/Pathology-GAN

27 October 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
DLDan Liu
Dan Liu
FYFrancesca Young
Francesca Young
KLKieran D. Lamb
Kieran D. Lamb
AQAdalberto Claudio Quiros
Adalberto Claudio Quiros
APAlexandrina Pancheva
Alexandrina Pancheva
KYKe Yuan
Ke Yuan
Computational prediction of protein structure from amino acid sequence alone has been achieved with unprecedented accuracy, yet the prediction of protein-protein interactions remains a challenge. Here, we assess the ability of protein language models (PLMs), routinely applied to protein folding, to be retrained for protein-protein interaction prediction. Existing models that exploit PLMs use a pre-trained PLM feature set, ignoring that the proteins are physically interacting. We propose PLM-interact, which goes beyond single proteins by jointly encoding protein pairs to learn their relationships, analogous to the next-sentence prediction task from natural language processing. This approach achieves state-of-the-art performance in a widely adopted cross-species protein-protein interaction prediction benchmark: trained on human data and tested on mouse, fly, worm, E. coli and yeast. In addition, we develop a fine-tuning method for PLM-interact to detect mutation effects on interactions. Finally, we report that the model outperforms existing approaches in predicting virus-host interaction at the protein level. Our work demonstrates that large language models can be extended to learn the intricate relationships among biomolecules from their sequences alone.

5 February 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
MCMarek Cmero
Marek Cmero
KYKe Yuan
Ke Yuan
COCheng Soon Ong
Cheng Soon Ong
JSJan Schröder
Jan Schröder
NCNiall M. Corcoran
Niall M. Corcoran
GMGeoff Macintyre
Geoff Macintyre
We present SVclone, a computational method for inferring the cancer cell fraction of structural variant (SV) breakpoints from whole-genome sequencing data. SVclone accurately determines the variant allele frequencies of both SV breakends, then simultaneously estimates the cancer cell fraction and SV copy number. We assess performance using in silico mixtures of real samples, at known proportions, created from two clonal metastases from the same patient. We find that SVclone’s performance is comparable to single-nucleotide variant-based methods, despite having an order of magnitude fewer data points. As part of the Pan-Cancer Analysis of Whole Genomes (PCAWG) consortium, which aggregated whole-genome sequencing data from 2658 cancers across 38 tumour types, we use SVclone to reveal a subset of liver, ovarian and pancreatic cancers with subclonally enriched copy-number neutral rearrangements that show decreased overall survival. SVclone enables improved characterisation of SV intra-tumour heterogeneity.